Philip D. Darney

No ORCID on file · 4 papers in corpus
article 2022
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens
·doi:10.1016/j.contraception.2022.04.002

ObjectivesTo describe ovulation inhibition and safety of daily oral ulipristal acetate (UPA) over 84 days.Study designThis multi-center phase 1 and/or 2 trial randomized participants to use oral ulipristal 10 mg or 5 mg daily or a 3 cycle r…

article 2010
Non-contraceptive applications of the levonorgestrel intrauterine system
International journal of women's health ·doi:10.2147/ijwh.s6344

Non-contraceptive applications of the levonorgestrel intrauterine system Maria Isabel Rodriguez, Philip D DarneyDepartment of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital and Bixby Center for Global Repr…

review 2009
Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2009.10.863

Intrauterine progestins, progesterone receptor modulators, and antagonists have many important current and potential gynecologic applications. This article will describe the evidence for use of intrauterine progestin for common gynecologic …

article 2000
Ovarian steroid and cytokine modulation of human endometrial angiogenesis
·doi:10.1093/humrep/15.suppl_3.67

A key mechanism underlying the cyclical growth of the endometrium is its ability to regenerate a vascular capillary network. In normal cycling human endometrium, angiogenesis is influenced by both endocrine and paracrine factors. Hormonal m…